PPARG and atherosclerosis: Furthermore, recent findings supporting a role of PPARγ in inflammation and cell growth have promoted the investigation of PPARγ agonists as experimental drugs for some chronic diseases such as atherosclerosis and cancer, among others [21]–[23].